Literature DB >> 18406338

Osteoclast-osteoblast communication.

Koichi Matsuo1, Naoko Irie.   

Abstract

Cells in osteoclast and osteoblast lineages communicate with each other through cell-cell contact, diffusible paracrine factors and cell-bone matrix interaction. Osteoclast-osteoblast communication occurs in a basic multicellular unit (BMU) at the initiation, transition and termination phases of bone remodeling. At the initiation phase, hematopoietic precursors are recruited to the BMU. These precursors express cell surface receptors including c-Fms, RANK and costimulatory molecules, such as osteoclast-associated receptor (OSCAR), and differentiate into osteoclasts following cell-cell contact with osteoblasts, which express ligands. Subsequently, the transition from bone resorption to formation is mediated by osteoclast-derived 'coupling factors', which direct the differentiation and activation of osteoblasts in resorbed lacunae to refill it with new bone. Bidirectional signaling generated by interaction between ephrinB2 on osteoclasts and EphB4 on osteoblast precursors facilitates the transition. Such interaction is likely to occur between osteoclasts and lining cells in the bone remodeling compartment (BRC). At the termination phase, bone remodeling is completed by osteoblastic bone formation and mineralization of bone matrix. Here, we describe molecular communication between osteoclasts and osteoblasts at distinct phases of bone remodeling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18406338     DOI: 10.1016/j.abb.2008.03.027

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  198 in total

1.  Factors that affect postnatal bone growth retardation in the twitcher murine model of Krabbe disease.

Authors:  Miguel Agustin Contreras; William Louis Ries; Srinivasan Shanmugarajan; Gonzalo Arboleda; Inderjit Singh; Avtar Kaur Singh
Journal:  Biochim Biophys Acta       Date:  2010-05-02

2.  Influence of creatine supplementation on bone quality in the ovariectomized rat model: an FT-Raman spectroscopy study.

Authors:  Renato Aparecido de Souza; Murilo Xavier; Fabiano Fernandes da Silva; Marco Túlio de Souza; Maira Gaspar Tosato; Airton Abrahão Martin; Julio Cezar de Melo Castilho; Wellington Ribeiro; Landulfo Silveira
Journal:  Lasers Med Sci       Date:  2011-08-12       Impact factor: 3.161

3.  Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development.

Authors:  Aditi Mukherjee; Peter Rotwein
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 4.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

Review 5.  Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?

Authors:  Baohong Zhao
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

6.  A physical mechanism for coupling bone resorption and formation in adult human bone.

Authors:  Thomas Levin Andersen; Teis Esben Sondergaard; Katarzyna Ewa Skorzynska; Frederik Dagnaes-Hansen; Trine Lindhardt Plesner; Ellen Margrethe Hauge; Torben Plesner; Jean-Marie Delaisse
Journal:  Am J Pathol       Date:  2008-12-18       Impact factor: 4.307

Review 7.  The molecular mechanism behind bone remodelling: a review.

Authors:  Peter Proff; Piero Römer
Journal:  Clin Oral Investig       Date:  2009-03-25       Impact factor: 3.573

Review 8.  Bone cell communication factors and Semaphorins.

Authors:  Takako Negishi-Koga; Hiroshi Takayanagi
Journal:  Bonekey Rep       Date:  2012-09-19

Review 9.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

10.  Bidirectional signaling through ephrinA2-EphA2 enhances osteoclastogenesis and suppresses osteoblastogenesis.

Authors:  Naoko Irie; Yasunari Takada; Yoshihiko Watanabe; Yumi Matsuzaki; Chie Naruse; Masahide Asano; Yoichiro Iwakura; Toshio Suda; Koichi Matsuo
Journal:  J Biol Chem       Date:  2009-03-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.